figshare
Browse
13058_2024_1774_MOESM1_ESM.pdf (1.54 MB)

Additional file 1 of TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer

Download (1.54 MB)
journal contribution
posted on 2024-02-01, 05:00 authored by Filipa Lynce, Laura E. Stevens, Zheqi Li, Jane E. Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M. Force, Tufia C. Haddad, Naoto Ueno, Vered Stearns, Antonio C. Wolff, Amy S. Clark, Jennifer R. Bellon, Edward T. Richardson, Justin M. Balko, Ian E. Krop, Eric P. Winer, Paulina Lange, E. Shelley Hwang, Tari A. King, Sara M. Tolaney, Alastair Thompson, Gaorav P. Gupta, Elizabeth A. Mittendorf, Meredith M. Regan, Beth Overmoyer, Kornelia Polyak
Additional file 1. Supplementary Figures and Methods.

Funding

The Inflammatory Breast Cancer Research Foundation National Cancer Institute, United States The Breast Cancer Research Foundation Susan G. Komen Incyte Milburn Foundation

History

Usage metrics

    Breast Cancer Research

    Categories

    Keywords

    Inflammatory breast cancerTriple negativeRuxolitinibPaclitaxelNeoadjuvant

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC